Financial results - MEDICOR-DR. GIUCA SRL

Financial Summary - Medicor-Dr. Giuca Srl
Unique identification code: 17274884
Registration number: J16/417/2005
Nace: 8622
Sales - Ron
20.222
Net Profit - Ron
93
Employee
2
The most important financial indicators for the company Medicor-Dr. Giuca Srl - Unique Identification Number 17274884: sales in 2023 was 20.222 euro, registering a net profit of 93 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Medicor-Dr. Giuca Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 34.366 43.263 37.680 37.824 31.753 43.074 34.813 40.615 36.944 20.222
Total Income - EUR 34.850 43.627 38.207 38.264 32.043 46.085 34.821 40.862 36.947 31.555
Total Expenses - EUR 15.497 15.739 14.973 14.088 16.670 17.150 22.386 22.294 24.135 31.146
Gross Profit/Loss - EUR 19.354 27.888 23.234 24.176 15.373 28.935 12.436 18.568 12.813 409
Net Profit/Loss - EUR 18.318 26.585 22.478 23.794 15.053 28.474 12.095 18.241 12.443 93
Employees 2 2 2 3 3 1 2 2 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -45.1%, from 36.944 euro in the year 2022, to 20.222 euro in 2023. The Net Profit decreased by -12.312 euro, from 12.443 euro in 2022, to 93 in the last year.

Check the financial reports for the company - Medicor-Dr. Giuca Srl

Rating financiar

Financial Rating -
Medicor-Dr. Giuca Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Medicor-Dr. Giuca Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Medicor-Dr. Giuca Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Medicor-Dr. Giuca Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Medicor-Dr. Giuca Srl - CUI 17274884

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 3.930 2.919 1.870 836 33.472 29.577 25.610 20.854 17.013 14.592
Current Assets 29.087 33.049 29.204 37.320 5.927 16.942 33.611 13.765 29.770 24.308
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 899 745 725 1.046 929 2.974 2.334 2.349 1.442 864
Cash 28.188 32.303 28.480 36.274 4.998 13.968 31.277 11.416 28.328 23.443
Shareholders Funds 31.686 34.632 22.531 23.846 15.104 28.525 40.079 30.116 12.492 12.547
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 1.387 1.393 8.600 14.309 24.295 18.030 19.142 4.411 35.143 26.246
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 24.308 euro in 2023 which includes Inventories of 0 euro, Receivables of 864 euro and cash availability of 23.443 euro.
The company's Equity was valued at 12.547 euro, while total Liabilities amounted to 26.246 euro. Equity increased by 93 euro, from 12.492 euro in 2022, to 12.547 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Medicor-Dr. Giuca Srl

Comments - Medicor-Dr. Giuca Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.